FC
Finepoint Capital’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-157,555
| Closed | -$10.1M | – | 22 |
|
|
2025
Q1 | $10.1M | Sell |
157,555
-4,380
| -3% | -$280K | 0.77% | 11 |
|
|
2024
Q4 | $19.7M | Buy |
161,935
+28,400
| +21% | +$3.45M | 1.2% | 9 |
|
|
2024
Q3 | $16.7M | Buy |
133,535
+700
| +0.5% | +$87.4K | 1.21% | 9 |
|
|
2024
Q2 | $21M | Sell |
132,835
-25,622
| -16% | -$4.05M | 5.96% | 6 |
|
|
2024
Q1 | $20.5M | Buy |
158,457
+13,100
| +9% | +$1.7M | 5.26% | 6 |
|
|
2023
Q4 | $14M | Hold |
145,357
| – | – | 4.42% | 13 |
|
|
2023
Q3 | $17.6M | Buy |
145,357
+19,900
| +16% | +$2.41M | 8.78% | 3 |
|
|
2023
Q2 | $14.4M | Buy |
125,457
+2,700
| +2% | +$309K | 4.97% | 12 |
|
|
2023
Q1 | $16.9M | Sell |
122,757
-8,700
| -7% | -$1.2M | 6.46% | 6 |
|
|
2022
Q4 | $17M | Buy |
+131,457
| New | +$17M | 5.51% | 9 |
|
|
2022
Q3 | – | Sell |
-211,000
| Closed | -$15.8M | – | 60 |
|
|
2022
Q2 | $15.8M | Buy |
+211,000
| New | +$15.8M | 5.47% | 5 |
|